Figure 2From: Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancerInhibition of EGFR signalling can be achieved with the use monoclonal antibodies cetuximab and panitumumab in RAS wild type patients.Back to article page